These days, investing in shares has become the equivalent of climbing the Swiss Alps bare-handed in the middle of the winter.
After the catastrophic results of investment funds during the last year, many investors are reluctant to place any money in the stock market. Are those fears justified?
History has proven once again that divination works as poorly in stock market investments as in other fields of human activity.
- Recommendations of experienced advisers have failed almost without exception.
- “Technical analysis,” the statistical approach to predicting stock market behaviour, has failed to protect banks.
- Thousands of professional investors have been wiped out.
- Sophisticated computer trading systems have not prevented traders from incurring enormous losses.
The main lesson to be drawn from the current situation is that, when it comes to investing in shares, methodology is everything. It is time to restate the validity of the six investment principles that have endured the best and the worst of times:
- Choose shares of solid companies, preferably those that pay dividends.
- Diversify your assets amongst different sectors and countries.
- Never place more than 5% of your savings in one single investment.
- Understand that nobody can predict with certainty when markets hit bottom or are about to crash. Never act blindly on someone else's advice. Always check things for yourself.
- Protect your assets with reasonable stop-loss orders.
- Make regular purchases of shares, monthly if possible, in order to ensure that you will also invest during periods of pessimism.
Today, May 16th 2009, the stock markets of the world present many opportunities, but after last year's losses, few are willing to take any risk.
I belong to those few and the following three belong to my favourite shares at this time. These are three multinational companies in the field of health and hygiene, making profits and paying good dividends:
- KIMBERLY CLARK (NYSE:KMB), which at the current share price, has a yield around 4.5% and a price/earnings ratio around 13.
- NOVARTIS (NYSE:NVS), which is paying a 4% dividend and has a price/earnings ratio around 12.
- JOHNSON AND JOHNSON (NYSE:JNJ), which is yielding around 3.5% and has a price/earnings ratio around 13.
Whatever you decide, don't trust anybody and check all facts for yourself. Remember that times of economic recession can be the best to rebuild an investment portfolio.
As Lao-Tzu recommended twenty-five centuries ago: “Don't make the mistake of believing that you know what you don't know, since truth is often paradoxical.”
[Image by extranoise under Creative Commons Attribution License. See the license terms under http://creativecommons.org/licenses/by/3.0/us]